Searched for
ZANUBRUTINIB
Glenmark to launch DCGI-approved cancer drug in IndiaGlenmark Pharmaceuticals is set to introduce zanubrutinib, a cancer treatment drug, in India. This follows approval from the Drugs Controll...- No revision, Glenmark Pharma sticking to full-year guidance: VS ManiVS Mani, CFO of Glenmark Pharma, discusses the company's strong performance in FY25 with an average of Rs 1,100 crore per quarter. Challeng...
- Glenmark to focus on becoming branded company, says Glenn SaldanhaGlenmark Pharmaceuticals, having navigated recent challenges, is shifting its focus to branded products for higher profit margins. The comp...
- Load More